Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
DKK0.19 - DKK6.00
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | DKK6.19M |
EV | DKK8.77M |
Shares Outstanding | 19.98M |
Beta | 0.13 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 5.70% |
EPS | -18.00% |
Operating Cash Flow | 18.80% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -308.64% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Stenocare A/S
STENO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Schnegelsberg, Thomas
Employees
8
Website
www.stenocare.dkIPO Date
2020-05-18
Headquarters
Nyholmsvej 4, Randers, Central Denmark Region, 8930, Denmark
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved